Cargando…

Toward a European definition for a drug shortage: a qualitative study

Background: Drug shortages are currently on the rise. In-depth investigation of the problem is necessary, however, a variety of definitions for ‘drug shortages’ are formulated in legislations, by different organizations, authorities, and other initiatives. For international comparison, the underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales: De Weerdt, Elfi, Simoens, Steven, Casteels, Minne, Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626567/
https://www.ncbi.nlm.nih.gov/pubmed/26578963
http://dx.doi.org/10.3389/fphar.2015.00253
_version_ 1782398125155024896
author De Weerdt, Elfi
Simoens, Steven
Casteels, Minne
Huys, Isabelle
author_facet De Weerdt, Elfi
Simoens, Steven
Casteels, Minne
Huys, Isabelle
author_sort De Weerdt, Elfi
collection PubMed
description Background: Drug shortages are currently on the rise. In-depth investigation of the problem is necessary, however, a variety of definitions for ‘drug shortages’ are formulated in legislations, by different organizations, authorities, and other initiatives. For international comparison, the underlying definition for drug shortages is important to allow appropriate interpretation of national databases and the results of scientific studies. The objective is to identify the different elements which should be considered in a uniform definition for drug shortages in the European Union (EU) and to detect the different conditions for reporting drug shortages. Materials and Methods: Definitions of drug shortages were searched in the scientific databases as well as in the gray literature. Similar topics were identified and organizations were contacted to formulate the reasoning underlying the definitions. Results: Over 20 different definitions for drug shortages were identified. A distinction is made between general definitions of drug shortages and definitions used for the reporting of drug shortages. Differences and similarities are observed in the elements within the definitions, e.g., when does a supply problem become a drug shortage, permanent and/or temporally shortages, the typology and time frame of a drug shortage. The moment a supply problem is considered as a shortage, can be defined at four levels: (i) demand side, (ii) supply side, (iii) delivery of a drug, and (iv) availability of a drug. Permanent discontinuations of drugs are not always covered in definitions for drug shortages. Some definitions only consider those drugs used for the treatment of serious diseases or drugs for which no alternative is available. Different time frames were observed, varying between 1 day and 20 days. Conclusion: Obtaining a uniform definition for drug shortages is important as well as identifying which conditions are preferable to report drug shortages in order to facilitate international benchmarking. This paper can be used as a guidance to point out all the different elements which should be considered to formulate a uniform definition to be applied in the EU.
format Online
Article
Text
id pubmed-4626567
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-46265672015-11-17 Toward a European definition for a drug shortage: a qualitative study De Weerdt, Elfi Simoens, Steven Casteels, Minne Huys, Isabelle Front Pharmacol Pharmacology Background: Drug shortages are currently on the rise. In-depth investigation of the problem is necessary, however, a variety of definitions for ‘drug shortages’ are formulated in legislations, by different organizations, authorities, and other initiatives. For international comparison, the underlying definition for drug shortages is important to allow appropriate interpretation of national databases and the results of scientific studies. The objective is to identify the different elements which should be considered in a uniform definition for drug shortages in the European Union (EU) and to detect the different conditions for reporting drug shortages. Materials and Methods: Definitions of drug shortages were searched in the scientific databases as well as in the gray literature. Similar topics were identified and organizations were contacted to formulate the reasoning underlying the definitions. Results: Over 20 different definitions for drug shortages were identified. A distinction is made between general definitions of drug shortages and definitions used for the reporting of drug shortages. Differences and similarities are observed in the elements within the definitions, e.g., when does a supply problem become a drug shortage, permanent and/or temporally shortages, the typology and time frame of a drug shortage. The moment a supply problem is considered as a shortage, can be defined at four levels: (i) demand side, (ii) supply side, (iii) delivery of a drug, and (iv) availability of a drug. Permanent discontinuations of drugs are not always covered in definitions for drug shortages. Some definitions only consider those drugs used for the treatment of serious diseases or drugs for which no alternative is available. Different time frames were observed, varying between 1 day and 20 days. Conclusion: Obtaining a uniform definition for drug shortages is important as well as identifying which conditions are preferable to report drug shortages in order to facilitate international benchmarking. This paper can be used as a guidance to point out all the different elements which should be considered to formulate a uniform definition to be applied in the EU. Frontiers Media S.A. 2015-10-30 /pmc/articles/PMC4626567/ /pubmed/26578963 http://dx.doi.org/10.3389/fphar.2015.00253 Text en Copyright © 2015 De Weerdt, Simoens, Casteels and Huys. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
De Weerdt, Elfi
Simoens, Steven
Casteels, Minne
Huys, Isabelle
Toward a European definition for a drug shortage: a qualitative study
title Toward a European definition for a drug shortage: a qualitative study
title_full Toward a European definition for a drug shortage: a qualitative study
title_fullStr Toward a European definition for a drug shortage: a qualitative study
title_full_unstemmed Toward a European definition for a drug shortage: a qualitative study
title_short Toward a European definition for a drug shortage: a qualitative study
title_sort toward a european definition for a drug shortage: a qualitative study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626567/
https://www.ncbi.nlm.nih.gov/pubmed/26578963
http://dx.doi.org/10.3389/fphar.2015.00253
work_keys_str_mv AT deweerdtelfi towardaeuropeandefinitionforadrugshortageaqualitativestudy
AT simoenssteven towardaeuropeandefinitionforadrugshortageaqualitativestudy
AT casteelsminne towardaeuropeandefinitionforadrugshortageaqualitativestudy
AT huysisabelle towardaeuropeandefinitionforadrugshortageaqualitativestudy